SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-020883
Filing Date
2017-04-18
Accepted
2017-04-18 14:32:52
Documents
2
Period of Report
2017-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v464412_8-k.htm 8-K 32708
2 EXHIBIT 10.1 v464412_ex10-1.htm EX-10.1 38993
  Complete submission text file 0001144204-17-020883.txt   73017
Mailing Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022 212-829-5546
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-55330 | Film No.: 17766759
SIC: 1000 Metal Mining